News|Articles|February 1, 2002

Pharmaceutical Technology

  • Pharmaceutical Technology-02-02-2002
  • Volume 26
  • Issue 2

Microbial Bioburden on Oral Solid Dosage Forms

Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.
External Link - article-9672.pdf

Articles in this issue

almost 24 years ago

Using Earned-Value Analysis to Better Manage Projects

almost 24 years ago

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I

almost 24 years ago

Modernizing Pharmaceutical Manufacturing

almost 24 years ago

The Role of Computational Fluid Dynamics in the Pharmaceutical Industry

almost 24 years ago

Available Guidance and Best Practices for Conducting Forced Degradation Studies

almost 24 years ago

Outsourcing Outlook

almost 24 years ago

Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content